Title: What determines the outcome of licensing deals in market for technology? Empirical analysis of sellers and buyers in biotechnology alliances
Authors: Shinya Kinukawa; Kazuyuki Motohashi
Addresses: Faculty of Global Media Studies, Komazawa University, 1-23-1 Komazawa, Setagaya-ku, Tokyo 154-8525, Japan ' Department of Technology Management for Innovation, School of Engineering, The University of Tokyo, 7-3-1 Hongo Bunkyo-ku, Tokyo 113-8656, Japan
Abstract: This paper empirically investigates factors affecting the relative bargaining strength of sellers and buyers in biotechnology markets, using transaction-level data for alliances between 1993 and 2008. Specifically, a two-tier stochastic frontier model is applied to our dataset for estimating the advantage of sellers and buyers, separately, and the advantage difference between them is regressed on possible determinants, such as scope of technology, stage of pharmaceutical R&D process, previous experience forming technology alliances, seller and buyer characteristics, and financial market conditions at the time of agreement. The results show that buyers were greatly advantaged over sellers in many alliances. However, a seller's bargaining position tended to improve significantly after the clinical research phase, as did repeating transactions with previous partners. US sellers also enjoyed an advantage over non-US buyers.
Keywords: technology market; technology alliances; pharmaceutical industry; bargaining strength; licensing deals; sellers; buyers; biotechnology alliances; strategical alliances; biotechnology markets; stochastic frontier modelling; clinical research; repeat transactions.
International Journal of Technology Management, 2016 Vol.70 No.4, pp.257 - 280
Available online: 12 Apr 2016Full-text access for editors Access for subscribers Purchase this article Comment on this article